Suppr超能文献

大型前庭神经鞘瘤的双重模式治疗后短暂亚急性面神经功能障碍。

Transient Subacute Facial Nerve Dysfunction After Dual Modality Treatment of Large Vestibular Schwannomas.

机构信息

Department of Otolaryngology-Head and Neck Surgery.

Department of Radiation Oncology, Vanderbilt University Medical Center.

出版信息

Otol Neurotol. 2021 Feb 1;42(2):e209-e215. doi: 10.1097/MAO.0000000000002893.

Abstract

OBJECTIVES

1: Describe subacute facial nerve paralysis after salvage stereotactic radiosurgery (SRS). 2: To analyze predictors of facial nerve weakness after dual modality treatment.

PATIENTS

Adult patients with Vestibular Schwannoma who underwent sub-total resection (STR) followed by salvage radiation.

INTERVENTIONS

Microsurgical resection of VS, stereotactic radiosurgery, intensity-modulated radiotherapy, proton radiotherapy.

MAIN OUTCOME MEASURES

Serial facial nerve function (House-Brackmann scale).

RESULTS

Thirteen patients who underwent dual modality treatment for large VS were included (mean age = 43.6 years, 77% females). The mean pre-operative tumor volume was 11.7 cm3 (SD = 6.5) and the immediate mean post-operative remnant volume was 1.5 cm3 (SD = 1.4) with a mean extent of resection of 86.7% (SD = 9.5). The mean salvage-free interval was 20.8 months (SD = 13.3). All patients had excellent one-year FN outcome (HB grade 1, 2) after resection. Three patients developed subacute facial nerve weakness after salvage SRS (4.2-9.4 months after SRS). This paralysis responded to high dose systemic steroids and no surgical interventions for facial rehabilitation were required. At last follow up (mean 61.6 months, SD = 28.5), facial nerve function was favorable (HB grade 1-2 in 12 patients and HB grade 3 in 1 patient). There were no significant associations between various predictors and subacute deterioration of facial nerve function after SRS.

CONCLUSIONS

Sub-acute transient facial nerve dysfunction can develop infrequently over a variable time frame after post-operative salvage SRS and usually responds to steroids. Patients should be adequately counseled about potential of transient deterioration of facial nerve function after salvage SRS.

摘要

目的

  1. 描述挽救性立体定向放射外科治疗后亚急性面神经麻痹。2. 分析双模式治疗后面神经无力的预测因素。

患者

接受次全切除术(STR)后行挽救性放疗的成人听神经鞘瘤患者。

干预措施

VS 的显微切除术、立体定向放射外科、调强放疗、质子放疗。

主要观察指标

面神经功能的连续评估(House-Brackmann 量表)。

结果

共纳入 13 例接受双模式治疗大型听神经鞘瘤的患者(平均年龄 43.6 岁,女性占 77%)。术前肿瘤平均体积为 11.7cm3(SD=6.5),术后即刻残余肿瘤平均体积为 1.5cm3(SD=1.4),平均切除程度为 86.7%(SD=9.5)。挽救性无进展间隔时间平均为 20.8 个月(SD=13.3)。所有患者在切除术后 1 年面神经功能均良好(HB 分级 1、2)。3 例患者在挽救性 SRS 后出现亚急性面神经无力(SRS 后 4.2-9.4 个月)。这种麻痹对大剂量全身类固醇治疗有反应,不需要手术干预进行面神经康复。末次随访(平均 61.6 个月,SD=28.5)时,面神经功能良好(12 例患者为 HB 分级 1-2,1 例患者为 HB 分级 3)。在 SRS 后面神经功能亚急性恶化与各种预测因素之间无显著相关性。

结论

手术后挽救性 SRS 后可能会在不同的时间范围内出现亚急性短暂性面神经功能障碍,通常对类固醇治疗有反应。应充分告知患者 SRS 后面神经功能暂时恶化的潜在风险。

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验